NewsRoom Articles - Page 8 of 208

ThursdayMay 01, 2025 10:00 am

Bacterial Meningitis Can Now Be Rapidly Diagnosed with New Test

A team of researchers based at the Amsterdam University Medical Center (UMC) have come up with a new test that can diagnose bacterial meningitis rapidly and with a high degree of accuracy. The test is conducted on cerebrospinal fluid and levels of a protein called CRP are measured. This same protein is also currently relied upon when diagnosing many other bacterial infections. The UMC team found that high CRP levels in cerebrospinal fluid are a highly reliable pointer to the presence of bacterial meningitis. At the moment, treatment for bacterial meningitis is often delayed because a lot of time passes…

ThursdayMay 01, 2025 9:45 am

Soligenix Inc. (NASDAQ: SNGX) HyBryte(TM) Paves Way for Breakthrough Treatment for Rare Skin Cancer

The global rare disease treatment market was estimated at $195.2 billion in 2024 and is anticipated to expand at a CAGR of 11.6% by 2030. SNGX’s HyBryte(TM) has demonstrated positive results in a study testing its use for patients with early-stage CTCL. HyBryte(TM) is a novel therapy based on photodynamic therapy, which combines light and a photosensitizer to target and destroy cancer cells. The development of treatments for rare diseases remains one of the most pressing challenges in modern medicine. Despite significant advancements in healthcare, many rare diseases still have no approved treatments, and patients often face grim prospects. The…

WednesdayApr 30, 2025 10:30 am

Calidi Biotherapeutics Inc. (NYSE American: CLDI) Committed to Advancing Cancer Care with Innovative RTNova Platform Research

Cancer statistics underscore the urgency of ongoing cancer research and the need for more effective cancer treatments. Calidi Biotherapeutics has announced preclinical results for its RTNova platform, a breakthrough in the delivery of transient gene therapy payloads to targeted tumors. The trials show an ability to deliver therapeutic payloads with precision while simultaneously attacking tumors. Cancer remains one of the deadliest diseases worldwide. Globally, the World Health Organization reports that the number of deaths will surpass 9.7 million in 2024, with a projected 20 million new cancer cases diagnosed; WHO also noted that it anticipates the cancer burden increasing an estimated 77% by…

WednesdayApr 30, 2025 10:00 am

AI Can Predict the Recurrence of Brain Tumors in Kids, Study Finds

A team of researchers has leveraged a technique called temporal learning to train an AI system to predict the likelihood of brain cancer recurring in kids diagnosed with gliomas. This AI model uses the magnetic resonance images periodically captured after the kids have received treatment for the gliomas. The study’s findings, based on analyzing multiple images, indicate that the AI model can produce predictions that are 89% accurate when compared to predictions made on the basis of just one image that have an accuracy rate of 50%., no different from flipping a coin. This approach, which looks for subtle changes…

WednesdayApr 30, 2025 9:45 am

Nutriband Inc. (NASDAQ: NTRB) Leadership Team: Driving Innovation and Shaping the Future of Global Healthcare

Sheridan was recently named as a finalist for the 2025 EY Entrepreneur of the Year Awards The CEO’s international perspective and expertise were further validated when he was featured in a recent BBC News article Chairman Serguei Melnik also participated in a market interview where he spoke about Nutriband’s mission, achievements and plans for the future Nutriband (NASDAQ: NTRB) is earning widespread recognition for the board’s leadership, expertise and innovation across a variety of platforms. Sheridan has recently been acknowledged in several high-profile ways that affirm his growing influence as a respected professional in the healthcare and business sectors. From being…

TuesdayApr 29, 2025 9:00 am

Calidi Biotherapeutics Inc. (NYSE American: CLDI) Reports Innovative RTNova Platform Research, Exemplifies Pivotal Role of Research

“Research on the treatment of cancer is fundamental to improving outcomes for all patients affected by the disease,” reports the National Cancer Institute. CLDI is reporting preclinical results for its systemic RTNova platform, which has successfully delivered transient gene therapy payloads to targeted tumors. “With this breakthrough, we can use our platform to develop multiple assets for various indications,” says CEO. Cancer remains one of the most formidable health challenges worldwide, necessitating relentless research to uncover effective treatments. Continuous scientific inquiry has led to groundbreaking therapies, offering hope to millions. A recent development in this arena is Calidi Biotherapeutics’ (NYSE…

FridayApr 25, 2025 10:30 am

Adageis Offering Comprehensive Healthcare AI Tools to Support Profitable Shift to Value-Based Care

Adageis offers an AI-powered financial technology platform tailored to healthcare providers seeking a financially positive transition to value-based care. The company’s patented analytics engine predicts revenue performance and simplifies contract reimbursement analysis to maximize financial efficiency. Adageis acts as an advocate for providers, helping them understand what payments they should expect from insurers. The platform integrates with over 90 EHR systems and supports providers through improved cash flow and access to funding. With growing adoption, Adageis continues to expand investor partnerships and develop superior tools for smaller healthcare practices. Adageis, a forward-thinking healthcare technology company, has a comprehensive suite of…

FridayApr 25, 2025 10:00 am

Scientists ID Bacteria That Could Be Behind Multiple Sclerosis Development

A new study focusing on twins has found that individuals with a larger presence of certain bacteria types could have a higher likelihood of developing multiple sclerosis. These findings could offer new ways to halt the disease’s progression or prevent it altogether. The team was led by researchers based at Ludwig Maximilian University in Munich and they discovered that two specific kinds of bacteria occurred more frequently in individuals diagnosed with MS, and those same kinds of bacteria were present in mice that developed this condition. The bacteria in question are Lachnoclostridium and Eisenbergiella tayi, the team indicated in their…

ThursdayApr 24, 2025 10:00 am

How Stem Cells Help in Blood Cancer Treatment

Stem cells are the “master cells” within the body because they can grow into any needed type of specialized cell in one’s body. As cancer treatment advances, these cells are proving to be a lifesaver for many people diagnosed with blood cancers like leukemia, myeloma and lymphoma. MGM Cancer Institute’s hemato-oncologist Doctor Gopinath explains that stem cells play the role of making all blood cells by producing platelets, white blood cells and red blood cells. Each of these types of cells plays a critical role in survival. For example, white blood cells fight infections while red blood cells transport needed…

TuesdayApr 22, 2025 10:00 am

UnitedHealth Records Lower Revenue as Medical Advantage Use Grows

UnitedHealth Group, the largest health insurance firm in the U.S., has reduced its revenue forecast for 2025 after its customers on Medicare Advantage made use of their policies a lot more than the company had anticipated. The first quarter of the year registered a lower financial performance than the company had expected. The stocks of the firm tumbled after this news on Thursday and the report released shook insurance stocks across the board. UnitedHealth said that MA plans saw more activity than the company had projected for the year. This was particularly evident in outpatient services and doctor visits, all…